Treatment completion among TB patients returned to the community from a large urban jail

Journal of Community Health

Volumn 32, Issue 2, 2007, Pages 135-147

  Kim, Seijeoung ^a   Crittenden, Kathleen ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Directly observed therapy; Jail inmates; Patient compliance; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIRECTLY OBSERVED THERAPY; FEMALE; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRISONER; RACE DIFFERENCE; SOCIOECONOMICS; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; CHICAGO; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PRISONERS; RETROSPECTIVE STUDIES; SOCIAL ADJUSTMENT; TUBERCULOSIS;

EID: 34247871291     PISSN: 00945145     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10900-006-9036-2     Document Type: Article

References (44)

1. World Health Organization. Global tuberculosis control: Surveillance, planning, financing. Geneva, Switzerland: World Health Organization, 2005. Report No.: WHO/HTM/TB/2005.349.
2. Centers for Disease Control and Prevention. Reported Tuberculosis in the United States, 2001. Atlanta, GA: U.S. Department of Health and Human Services, CDC, 2002.
3. Blumberg H, Bock N. Georgia TB Reference Guide. Atlanta, GA: Atlanta Tuberculosis Prevention Coalition, 1999.
4. Centers for Disease Control, Prevention. Prevention and Control of Tuberculosis in Correctional Facilities Recommendations of the Advisory Council for the Elimination of Tuberculosis. Morb Mortal Wkly Rep 1996; 45:1-27.
5. Simone P, Puisis M Tuberculosis screening. In: Puisis M, ed. Clinical Practice in Correctional Medicine. St. Louis: Mosby. 2006:101-108.
6. Bick J. Tuberculosis in Corrections: 2002 Update. HEPP News. HIV Education Prison Project 2002; 5:1-9.
7. McNeil J, Lobato M, Moore M. An unanswered health disparity: tuberculosis among correctional inmates, 1993 through 2003. Am J Public Health 2005; 95:1800-1805.
8. White MC, Tulsky JP, Portillo CJ, Menendez E, Cruz E, Goldenson J. Tuberculosis prevalence in an urban jail: 1994 and 1998. Int J Tuberc Lung Dis 2001; 5:400-404.
9. Lopez J, Welvaart H, Ford W, Kerndt P. HIV prevalence and risk behaviors among patients attending Los Angeles County Tuberculosis clinics: 1993-1996. Ann Epidemiol 1998; 8:168-174.
10. Brock NN, Reeves M, LaMarre M, DeVoe B. Tuberculosis case detection in a state prison system. Public Health Rep 1998; 113:359-364.
11. White VL, Moore-Gillon J. Resource implications of patients with multidrug resistant tuberculosis. Thorax 2000; 55:962-963.
12. Center for Disease Control, Prevention. Trends in Tuberculosis - United States, 1998-2003. Morb Mortal Wkly Rep 2004; 53:209-214.
13. Center for Disease Control, Prevention. Treatment of Tuberculosis. Morb Mortal Wkly Rep 2003; 52:1-77.
14. Lorvick J, Thompson S, Edlin BR, Kral AH, Lifson AR, Watters JK.. Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community. J Urban Health 1999; 76:461-467.
15. Shi L, Stevens G. Vulnerable Populations in the United States. JAMA 2005; 293:1924-1925.
16. Harlow C. Profile of jail inmates, 1996. Washington, DC: U.S. Department of Justice. Bureau of Justice Statistics Special Report; 1998. Report No.: NCJ)164620. Available from: http://www.ojp.usdoj.gov/bjs/abstract/pji96.htm [accessed 2005 November 14].
17. Driver CR, Matus SP, Bayuga S, Winters AI, Munsiff SS. Factors associated with tuberculosis treatment interruption in New York City. J Public Health Manag Pract 2005; 11:361-368.
18. Tulsky JP, White MC, Dawson C, et al. Screening for tuberculosis in jail and clinic follow-up after release. Am J Public Health 1998; 88:223-226.
19. Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. 11 years of community-based directly observed therapy for tuberculosis. JAMA 1995; 274:945-951.
20. World Health Organization. Tuberculosis control in prison: A manual for programme managers. Geneva, Switzerland: World Health Organization; 2001. Report No.: WHO/CDS/TB/2001.281.
21. World Health Organization. Tuberculosis. Geneva, Switzerland: World Health Organization; 2000. Available from: http://www.who.int/inf-fs/en/fact104. html [Accessed 2005 November 14].
22. Chicago Department of Public Health. Tuberculosis morbidity report. Chicago, IL: Chicago Department of Public Health, West Side Center for Disease Control, 1998.
23. Bayer R, Stayton C, Desvarieux M, Healton C, Landesman S, Tsai WY. Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary?. Am J Public Health 1998; 88:1052-1058.
24. Heymann SJ, Sell R, Brewer TF. The influence of program acceptability on the effectiveness of public health policy: a study of directly observed therapy for tuberculosis. Am J Public Health 1998; 88:442-445.
25. Farmer P. Social scientists and the new tuberculosis. Soc Sci Med 1997; 44:347-358.
26. Barnhoorn FA, Geest S. Letter to the editor. Soc Sci Med 1997; 45:1597-1599.
27. Farmer, PE, J Bayona, M Becerra, J Furin et al. The Dilemma of MDR-TB in the Global Era. Int J Tuberc Lung Dis 1998; 2:869-876.
28. Mangura B, Napolitano E, Passannante M, et al. Directly observed therapy (DOT) is not the entire answer: an operational cohort analysis. Int J Tuberc Lung Dis 2002; 6:654-661.
29. Donovan JL, Blake DR. Patient noncompliance: deviance of reasoned decision-making. Soc Sci Med 1992; 34:507-513.
30. Uwaoma UE, Gwynn RC, Medard F, Berthaud V, El-Sadr W. Socio-clinical factors associated with treatment completion among TB patients in the Harlem DOT program, 1993-1998. International Conference of the American Thoracic Society; 2001 May; San Francisco, CA. Available from: http://www.harlemtbcenter.org/ abstracts/abs_2001_socio_factors_treat_compl_dot.htm [Accessed 2005 November 14].
31. Lobato M, Reves R, Jasmer R, Grabau J, Bock N, Shang N. Adverse Events and Treatment Completion for Latent Tuberculosis in Jail Inmates and Homeless Persons. Chest 2005; 127:1296-1303.
32. Tanguis HG, Cayla JA, Garcia Olalla PG, Jansa JM, Brugal MT. Factors predicting non-completion of tuberculosis treatment among HIV-infected patients in Barcelona (1987-1996). Int J Tuberc Lung Dis 2000; 4:55-60.
33. Kim S, Crittenden K. Risk factors for tuberculosis among inmates: A retrospective analysis. Public Health Nurs 2005; 22:108-118.
34. Isaac Ray Center. Cermak Health Services. Available from: http://www.isaacraycenter.com/Cermak_/cermak_.html [Accessed 2005 November 14].
35. John Howard Association. Court monitoring report. Chicago, IL: John Howard Association, 2005.
36. Gilliard D, Beck AJ. Prisoners in 1997. Bureau of Justice Statistics Bulletin. Washington, DC: U.S. Department of Justice, 1998.
37. White MC, Tulsky JP, Menendez E, Goldenson J, Kawamura LM. Incidence of TB in inmates with latent TB infection: 5-year follow-up. Am J Prev Med 2005; 29:295-301.
38. Morisky DE, Ebin VJ, Malotte CK, Coly A, Kominski G. Assessment of tuberculosis treatment completion in an ethnically diverse population using two data sources: Implications for treatment interventions. Eval Health Prof 2003; 26:43-58.
39. Matteelli A, Casalini C, Raviglione MC, El-Hamad I, Scolari C, Bombana E, Bugiani M, Caputo M, Scarcella C, Carosi G. Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy. Am J Respir Crit Care Med 2000; 162:1653-155.
40. Aebischer-Perone S, Bovier P, Pichonnaz C, Rochat T, Loutan L. Tuberculosis in undocumented migrants, Geneva. Emerg Infect Dis 2005; Available from: http://www.cdc.gov/ncidod/EID/vol11no02/03-0215.htm [Accessed 2006 June 14].
41. Menzies D. Controlling tuberculosis among foreign born within industrialized countries: expensive band-aids. Am J Respir Crit Care Med 2001; 164:914-915.
42. Lebouché B, Yazdanpanah Y, Gérard Y, Sissoko D, Ajana F, Alcaraz I, Boitte P, Cadoré B, Mouton Y. Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998. HIV Medicine 2006; 7:140.
43. Asch S, Leake B, Gelberg L. Does fear of immigration authorities deter tuberculosis patients from seeking care?. West J Med 1994; 161:373-376.
44. Ditton P Mental Health and Treatment of Inmates and Probationers. Washington, DC: U.S. Department of Justice, Bureau of Justice Statistics; 1999. Report No.: NCJ 174463; Available from: http://www.ojp.usdoj.gov/bjs/pub/pdf/ mhtip.pdf [Accessed 2006 June 14]